{
    "id": 3866,
    "fullName": "PDGFRA D842Y",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PDGFRA D842Y lies within the protein kinase domain of the Pdgfra protein (UniProt.org). D842Y confers a gain of function on the Pdgfra protein as indicated by increased ligand-independent phosphorylation of Pdgfra in culture (PMID: 15928335, PMID: 22745105).",
            "references": [
                {
                    "id": 272,
                    "pubMedId": 15928335,
                    "title": "PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15928335"
                },
                {
                    "id": 2167,
                    "pubMedId": 22745105,
                    "title": "Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22745105"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5156,
        "geneSymbol": "PDGFRA",
        "terms": [
            "PDGFRA",
            "CD140A",
            "PDGFR-2",
            "PDGFR2"
        ]
    },
    "variant": "D842Y",
    "createDate": "03/18/2015",
    "updateDate": "06/26/2019",
    "referenceTranscriptCoordinates": {
        "id": 118773,
        "transcript": "NM_006206",
        "gDna": "chr4:g.54285925G>T",
        "cDna": "c.2524G>T",
        "protein": "p.D842Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7188,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) inhibited Pdgfra phosphorylation and decreased proliferation in transformed human cells expressing PDGFRA D842Y in culture (PMID: 24132921).",
            "molecularProfile": {
                "id": 3676,
                "profileName": "PDGFRA D842Y"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2242,
                    "pubMedId": 24132921,
                    "title": "Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24132921"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7189,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Crenolanib inhibited Pdgfra phosphorylation and decreased proliferation in transformed human cells expressing PDGFRA D842Y in culture (PMID: 24132921).",
            "molecularProfile": {
                "id": 3676,
                "profileName": "PDGFRA D842Y"
            },
            "therapy": {
                "id": 705,
                "therapyName": "Crenolanib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2242,
                    "pubMedId": 24132921,
                    "title": "Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24132921"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3676,
            "profileName": "PDGFRA D842Y",
            "profileTreatmentApproaches": [
                {
                    "id": 2274,
                    "name": "PDGFR Inhibitor (Pan)",
                    "profileName": "PDGFRA D842Y"
                },
                {
                    "id": 2275,
                    "name": "PDGFR-alpha Inhibitor",
                    "profileName": "PDGFRA D842Y"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 118774,
            "transcript": "XM_005265743",
            "gDna": "chr4:g.54285925G>T",
            "cDna": "c.2524G>T",
            "protein": "p.D842Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 118775,
            "transcript": "XM_011534385",
            "gDna": "chr4:g.54285925G>T",
            "cDna": "c.2524G>T",
            "protein": "p.D842Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 118773,
            "transcript": "NM_006206",
            "gDna": "chr4:g.54285925G>T",
            "cDna": "c.2524G>T",
            "protein": "p.D842Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}